We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+3.57%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$578B
AUM Growth
+$59.6B
Cap. Flow
+$35.2B
Cap. Flow %
6.08%
Top 10 Hldgs %
31.21%
Holding
15,826
New
1,745
Increased
6,428
Reduced
6,082
Closed
1,423

Top Buys

Rank Stock Value
1
BA icon
Boeing
BA
+$830M
2
UNH icon
UnitedHealth
UNH
+$769M
3
AJG icon
Arthur J. Gallagher & Co
AJG
+$691M
4
AMZN icon
Amazon
AMZN
+$654M
5
BAC icon
Bank of America
BAC
+$634M

Sector Composition

Rank Sector Weight
1 Healthcare 3.13%
2 Technology 2.97%
3 Financials 2.19%
4 Consumer Discretionary 2.09%
5 Industrials 1.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SMDV icon
13401
PUT
ProShares Russell 2000 Dividend Growers ETF
SMDV
$710M
$13.5K ﹤0.01%
200
-6,800
-97% -$482K
PDSB icon
13402
CALL
PDS Biotechnology
PDSB
$12.9M
$13.5K ﹤0.01%
8,300
+7,400
+822% +$19.6K
NSLR
13403
CALL
Neostellar Capital Corp
NSLR
$278M
$13.5K ﹤0.01%
2,300
-8,300
-78% -$42.5K
TSHA icon
13404
PUT
Taysha Gene Therapies
TSHA
$1.9B
$13.5K ﹤0.01%
7,800
-5,500
-41% -$11.4K
EQS icon
13405
Equus Total Return
EQS
$16.1M
$13.5K ﹤0.01%
+12,250
New +$15.2K
FNA
13406
PUT
DELISTED
Paragon 28, Inc.
FNA
$13.4K ﹤0.01%
1,300
-900
-41% -$7.26K
ONLN icon
13407
CALL
ProShares Online Retail ETF
ONLN
$64.7M
$13.4K ﹤0.01%
+300
New +$13.7K
TYO icon
13408
PUT
Direxion Daily 7-10 Year Treasury Bear 3X ETF
TYO
$11.7M
$13.4K ﹤0.01%
+900
New +$12.6K
CERS icon
13409
PUT
Cerus
CERS
$601M
$13.4K ﹤0.01%
8,700
-14,900
-63% -$25.6K
ENFN
13410
PUT
DELISTED
Enfusion, Inc.
ENFN
$13.4K ﹤0.01%
1,300
+700
+117% +$6.77K
JFIN
13411
CALL
Jiayin Group
JFIN
$119M
$13.4K ﹤0.01%
2,100
-9,000
-81% -$60.2K
MSN icon
13412
Emerson Radio
MSN
$7.91M
$13.4K ﹤0.01%
+31,803
New +$14.8K
GHI icon
13413
CALL
Greystone Housing Impact Investors LP
GHI
$141M
$13.3K ﹤0.01%
1,300
-42,300
-97% -$508K
LGTY
13414
PUT
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$13.3K ﹤0.01%
1,200
+1,100
+1,100% +$12K
HSII
13415
PUT
DELISTED
Heidrick & Struggles
HSII
$13.3K ﹤0.01%
300
-900
-75% -$38.5K
PHLT
13416
CALL
DELISTED
Performant Healthcare Inc
PHLT
$13.3K ﹤0.01%
4,400
-100
-2% -$344
CIG icon
13417
PUT
CEMIG Preferred Shares
CIG
$5.52B
$13.3K ﹤0.01%
7,500
+4,290
+134% +$8.33K
MYE icon
13418
CALL
Myers Industries
MYE
$1.24B
$13.2K ﹤0.01%
1,200
-1,200
-50% -$14.5K
BRF icon
13419
PUT
VanEck Brazil Small-Cap ETF
BRF
$20.1M
$13.2K ﹤0.01%
1,200
+200
+20% +$2.66K
LUNA
13420
CALL
DELISTED
Luna Innovations Incorporated
LUNA
$13.2K ﹤0.01%
+6,100
New +$10.8K
ATLO icon
13421
PUT
AMES National
ATLO
$280M
$13.1K ﹤0.01%
800
+600
+300% +$10.4K
PRLD icon
13422
Prelude Therapeutics
PRLD
$443M
$13.1K ﹤0.01%
10,297
-4,928
-32% -$6.54K
UAMY icon
13423
CALL
United States Antimony
UAMY
$825M
$13.1K ﹤0.01%
7,400
+7,300
+7,300% +$7.32K
DNTH icon
13424
PUT
Dianthus Therapeutics
DNTH
$6.49B
$13.1K ﹤0.01%
600
+200
+50% +$5.14K
STVN icon
13425
PUT
Stevanato
STVN
$5.75B
$13.1K ﹤0.01%
600
-400
-40% -$8.02K

Similar funds

Citadel Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Citadel Advisors deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.

By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.

  • Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
  • Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
  • Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
  • Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
  • Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
  • Citadel Advisors opened 1,745 new positions and closed 1,423 in Q4 2024.
  • Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.

Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.